Adam George, PharmD
Adam George, PharmD. has more than a decade of experience in clinical drug development and regulatory affairs. He uses his experience working at FDA, and in industry, to help clients prepare for FDA meetings and regulatory submissions.
Before joining 3D, Adam was a regulatory affairs therapeutic area head for oncology and respiratory drugs, biologics, at Teva Pharmaceuticals. Prior to joining Teva, he spent more than six years at FDA as a clinical reviewer in the Division of Hematology Products (DHP), Office of Hematology Oncology Products (OHOP) and as a senior regulatory reviewer in the Office of Prescription Drug Promotion (OPDP).
As a clinical reviewer in DHP he was responsible for the clinical review of NDAs, BLAs, and INDs for drugs to treat hematologic malignancies. He has reviewed and recommended products to be discussed at the Oncologic Drugs Advisory Committee as well as reviewed and recommended products for Fast Track designation, priority review, and Break Through therapy designation.
At OPDP Adam was responsible for the review of promotional materials for hematology-oncology products and anti-infective agents. He holds a Doctor of Pharmacy degree from Temple University.